1-16 of 16
Keywords: Anthracyclines
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2023) 101 (4): 234–239.
Published Online: 20 April 2023
... with or without gemcitabine and associated with anthracyclines. A lower median RFS and OS were reported in patients with PBA compared to those with SBA, but the difference observed was not statistically significant. Patients with PBA had a lower median age at the diagnosis (38 vs. 75). Conclusion: In our analysis...
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2013) 85 (5): 278–282.
Published Online: 06 November 2013
... of this study was to estimate the rate of adverse events in BRCA1/2 -associated breast cancer patients receiving anthracycline-based chemotherapy compared to patients without mutation. The authors also compared radiotherapy toxicity in these 2 groups. Methods: The analysis included 270 early-stage breast cancer...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2010) 77 (Suppl. 1): 14–17.
Published Online: 02 February 2010
...Matteo Clavarezza; Marco Venturini HER2-positive breast cancer is characterized by high chemosensitivity. Anthracycline-based chemotherapy is recognized as a very effective adjuvant treatment in HER2-positive disease. One of the possible explanations is the co-amplification of TOPO II-alpha...
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (1989) 46 (5): 285–287.
Published Online: 26 June 2009
... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Esorubicin Sarcoma Chemotherapy Anthracyclines Original Papers Oncology 1989;46:285-287 < 1989 S. Karger AG, Basel 0030 2414 89 0465 0285 $ 2.75/0 Phase II Study...
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (1986) 43 (1): 60–66.
Published Online: 23 June 2009
... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Doxorubicin Anthracyclines...
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (1984) 41 (1): 55–60.
Published Online: 11 June 2009
.... Doxorubicin Anthracyclines Sarcoma cells Cellular pharmacokinetics Cytotoxicity 11 6 2009 Oncology 41: 55-60 (1984) Cellular Pharmacokinetics of Doxorubicin in Cultured Mouse Sarcoma Cells Originating from Autochthonous Tumors Tan Nguyen-Ngoc, Patricia Vrignaud, Jacques Robert Fondation...
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2002) 63 (Suppl. 1): 47–56.
Published Online: 13 November 2002
...Luca Gianni The anti-HER2 monoclonal antibody Herceptin ® demonstrates significant clinical benefits in patients with HER2-positive metastatic breast cancer (MBC). However, the combination of Herceptin plus anthracyclines, although efficacious, demonstrated a higher than expected incidence...